Computational approaches to Immuno-Oncology drug development
Add to your list(s)
Download to your calendar using vCal
If you have a question about this talk, please contact .
Abstract: Immune modifying approaches for the treatment of cancer have been wildly successful, yet approved therapies are only the tip of the iceberg. Drugs in earlier stages of development represent a broad class of agents with numerous challenges for a successful drug discovery programme. For example, how do we demonstrate intra-tumoural immune modulation from a peripheral blood sample? How do identify the patients most likely to respond to immune-therapy? Here I will discuss the bioinformatic approaches we are taking to address these questions within AstraZeneca.
This talk is part of the Computational and Systems Biology series.
This talk is included in these lists:
Note that ex-directory lists are not shown.
|